Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

NCT05667740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: Gamma-PN3
BIOLOGICAL: Prevenar-13
BIOLOGICAL: Pneumovax-23
DRUG: Placebo

Sponsor

GPN Vaccines